Regulatory document
Pre-Approval Inspections: New Animal Drug Applications (NADA); Abbreviated New Animal Drug…
FDA Compliance Program Manual · Guidance · USA · Aug 7, 2024
Key facts
| Title | Pre-Approval Inspections: New Animal Drug Applications (NADA); Abbreviated New Animal Drug Applications (ANADA); Investigational New Animal Drug Applications (INAD); Generic Investigational New Animal Drug (JINAD) Applications; and Conditional New Animal Drug Applications (CNADA) |
|---|---|
| Issuer | FDA Compliance Program Manual |
| Source | FDA Compliance Program Manual |
| Document type | Guidance |
| Country or region | USA |
| Date | Aug 7, 2024 |
| Document | fda.gov |
| Issuer website | fda.gov |
At a glance
- Yes Full text searchable in Orca1
- 10–99 Documents from this issuer in Orca1
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Global regulations and guidance
Regulations, guidance and official notices from medical device and medicines regulators worldwide, collected by Orca1 from each issuer's website. Only the title, issuer, date and link are shown here; the full text is searchable in Orca1.
Source: Medical device and medicines regulators and agencies as named on each record (EMA, MHRA, TGA, CDSCO, PMDA, NMPA, Health Canada, HSA, the FDA and others), collected by Orca1 from each issuer's website · Source date: